We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NPAC:NASDAQNew Providence Acquisition Corp. III Analysis

Data as of 2026-05-19 - not real-time

$10.34

Latest Price

8/10Risk

Risk Level: High

Executive Summary

NPAC trades at $10.34, just above its 20‑day SMA of 10.32 and within a narrow band of support (10.31) and resistance (10.36), while the RSI sits at 59 and the MACD histogram is marginally positive, indicating a modest bullish technical bias.
However, the company has zero revenue, negative book value per share (-$0.315), and a P/E of 33.35 versus an industry average of 16.69, suggesting the stock is materially overvalued. The beta is near zero (0.015) and 30‑day volatility is low (1.95%), but trading volume has collapsed to an average of 339 shares versus a 3‑month average of 113,521, creating a pronounced liquidity risk. With no dividend, negative operating cash flow, and a SPAC structure that hinges on a future business combination, the investment profile is high‑risk and speculative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Technical indicators show mild bullishness but price is near resistance
  • Extremely low trading volume limits entry/exit flexibility
  • Fundamentals remain absent with zero revenue and negative book value

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential upside if a value‑creating business combination is announced
  • Current price is modestly above short‑term support, offering limited downside
  • Market sentiment is extremely greedy (Fear & Greed Index 89.29), supporting speculative buys

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Long‑term value hinges entirely on a successful merger, which is uncertain
  • Persistent negative cash flows and lack of operating history increase risk
  • Low beta and low volatility provide some defensive characteristics if the SPAC completes

Key Metrics & Analysis

Financial Health

P/E Ratio33.4
ROA-0.27%
P/B Ratio-32.8
Op. Cash Flow$-739616
Free Cash Flow$-410450
Industry P/E16.7

Technical Analysis

TrendBullish
RSI59.2
Support$10.31
Resistance$10.36
MA 20$10.32
MA 50$10.30
MA 200$10.25
MACDBullish
VolumeDecreasing
Fear & Greed Index89.29

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.02
Volatility1.95%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.